Capella 4055 Assessment 4

Capella 4055 Assessment 4

Student Name

Capella University

NURS-FPX4055 Optimizing Population Health through Community Practice

Prof. Name

Date

Health Promotion Plan Presentation

Good morning, and welcome. We appreciate your presence at today’s health promotion session. This presentation focuses on preventing Human Papillomavirus (HPV) infections in adolescents and young adults aged 11 to 26 residing in Schwenksville, Pennsylvania. The session aims to provide comprehensive information about HPV, its association with cancer, the importance of timely vaccination, and effective communication strategies with healthcare providers and families. Our approach aligns with the SMART goals developed in collaboration with our stakeholders and the national Healthy People 2030 objectives. Let us now proceed with the presentation overview.

Presentation Roadmap

In today’s session, we will:

• Present essential facts about HPV, its modes of transmission, and its connection to various cancers.
• Emphasize the effectiveness, safety, and timing of the HPV vaccine.
• Motivate attendees to schedule the HPV vaccine within 30 days.
• Enhance participants’ communication skills regarding HPV vaccination with providers and family.
• Incorporate interactive segments to maintain engagement.
• Conclude with a quiz and survey to evaluate participant understanding and confidence.

Key Information About HPV and Its Link to Cancer

HPV is one of the most prevalent viruses transmitted via skin-to-skin and sexual contact. In Pennsylvania, the full vaccination rate among adolescents stands at 68.7%, but rural regions such as Schwenksville show significantly lower coverage at 48.7%, which correlates with high HPV-associated cancer rates (PA.gov, 2025). Increasing vaccination in these communities is critical.

HPV is a causative factor for several cancers, including cervical, anal, throat, and genital malignancies. Persistent infections with high-risk strains like HPV types 16 and 18 can cause cellular changes that lead to cancer (Huber et al., 2021). Early detection remains essential as infections may remain symptomless for years. Although many cases resolve naturally, chronic infections significantly raise cancer risk. Preventative strategies, especially timely immunization and regular screenings, are essential in reducing HPV-related cancers.

Benefits of Timely HPV Vaccination

Vaccinating early, ideally at ages 11 or 12, provides multiple benefits:

Strategies for Discussing HPV Vaccination

Effective communication about HPV vaccination is key. The following strategies may aid these conversations:

• Using Reliable Data: Citing credible sources such as the CDC and WHO helps correct misinformation.
• Asking Thoughtful Questions: Engaging in inquiry (e.g., “What are the long-term benefits?”) promotes mutual understanding (Kassymbekova et al., 2023).
• Dispelling Myths: Clarify that the vaccine prevents disease, not influences behavior, to counter common misconceptions.

Developed SMART Goals with the Participants

We structured our session around the following SMART goals:

• Knowledge Acquisition: 90% of attendees will identify three key facts about HPV and its cancer link, assessed through a quiz.
• Commitment to Vaccination: 80% of participants will pledge to schedule their first HPV vaccine dose within 30 days.
• Improved Communication: 85% will report increased confidence discussing vaccination with family and providers, enhanced through activities and practice scenarios.

These goals aim to empower attendees with the knowledge and tools to take proactive health measures.

Session Evaluation on Developed SMART Goals

The session yielded positive results in most areas. First, 92.5% of participants identified at least three facts about HPV and its cancer link, surpassing our knowledge goal. Second, 75% verbally committed to initiating vaccination within 30 days, which fell slightly short of the 80% target. Lastly, 85% reported improved confidence in discussing HPV vaccination, meeting our communication goal.

However, some teens were hesitant to commit immediately and preferred family discussions first. Additionally, a few attendees expressed discomfort with addressing myths due to limited preparation. Future sessions can be enhanced by:

• Encouraging family discussions during the session.
• Incorporating role-play to rehearse myth-busting.
• Extending the session or scheduling a follow-up to reinforce decisions and confidence.

Session Evaluation on Healthy People 2030 Objectives

This session advanced Healthy People 2030 goals by raising awareness and improving knowledge on HPV-related health issues. The educational content increased understanding of vaccine-preventable cancers and the value of early immunization. The 92.5% factual knowledge gain and 85% rise in communication confidence reflect substantial progress.

Nevertheless, the 75% commitment rate to vaccine initiation reveals a need for stronger engagement strategies to meet national targets. Participants need further support to address safety concerns and misinformation. Future enhancements may include engaging families directly, emphasizing current safety data, and issuing post-session reminders. These strategies can improve vaccine uptake and foster long-term public health gains (Xu et al., 2024).

Conclusion

In conclusion, HPV vaccination plays a critical role in cancer prevention among youth in Schwenksville, PA. Our SMART goals framed a structured and interactive educational experience. While knowledge gains were significant, additional improvements can further align future efforts with Healthy People 2030 targets. Through awareness, timely immunization, and confident communication, we can promote a healthier future.

References

Cheng, L., Wang, Y., & Du, J. (2020). Human papillomavirus vaccines: An updated review. Vaccines, 8(3), 391. https://doi.org/10.3390/vaccines8030391

Hoes, J., Pasmans, H., Schurink-van ’t Klooster, T. M., van der Klis, F. R. M., Donken, R., Berkhof, J., & de Melker, H. E. (2021). Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics, 18(1). https://doi.org/10.1080/21645515.2021.1908059

Huber, J., Mueller, A., Sailer, M., & Regidor, P.-A. (2021). Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women’s Health, 17, 174550652110207. https://doi.org/10.1177/17455065211020702

Capella 4055 Assessment 4

Kassymbekova, F., Zhetpisbayeva, I., Tcoy, E., Dyussenov, R., Davletov, K., Rommel, A., & Glushkova, N. (2023). Exploring HPV vaccine knowledge, attitudes, barriers and information sources among parents, health professionals and teachers in Kazakhstan: A mixed-methods study protocol. BMJ Open, 13(9), e074097. https://doi.org/10.1136/bmjopen-2023-074097

PA.gov. (2025). Dear VFC provider. https://www.pa.gov/content/dam/copapwp-pagov/en/health/documents/topics/documents/programs/immunizations

Xu, H., Zhang, J., Wang, H., Wang, X., & Yang, Y. (2024). Community-based interventions for increasing HPV vaccination uptake: A meta-analysis. Preventive Medicine Reports, 38, 102394. https://doi.org/10.1016/j.pmedr.2024.102394